VF
GBT

Virtu Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Virtu Financial’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,177
Closed -$531K – 2228
2021
Q2 		$531K Buy
+15,177
New +$593K 0.05% 445
2021
Q1 		– Sell
-6,074
Closed -$263K – 2247
2020
Q4 		$263K Sell
6,074
-242
-4% -$11.9K 0.03% 704
2020
Q3 		$348K Sell
6,316
-3,296
-34% -$209K 0.06% 385
2020
Q2 		$607K Buy
+9,612
New +$659K 0.07% 308
2019
Q4 		$441K Sell
5,548
-4,411
-44% -$261K 0.04% 476
2019
Q3 		$483K Sell
9,959
-7,247
-42% -$378K 0.04% 527
2019
Q2 		$905K Buy
17,206
+12,532
+268% +$720K 0.05% 323
2019
Q1 		$247K Buy
+4,674
New +$230K 0.01% 889
2018
Q4 		– Sell
-24,241
Closed -$921K – 2113
2018
Q3 		$921K Buy
24,241
+18,494
+322% +$819K 0.06% 359
2018
Q2 		$260K Buy
5,747
+615
+12% +$28K 0.02% 1267
2018
Q1 		$248K Buy
+5,132
New +$286K 0.01% 1198
2017
Q4 		– Sell
-11,450
Closed -$356K – 3198
2017
Q3 		$356K Buy
+11,450
New +$322K 0.02% 1220

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Virtu Financial's GBT Position: Q3 2021 in Review

Virtu Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2021, closing a stake of 15,177 shares — an estimated $531K sold.

Virtu Financial first reported a position in GBT in Q3 2017 and held it in 12 quarters. The position peaked at $921K in Q3 2018. 187 funds tracked by Wall St. Rank hold GBT as of Q3 2021.

  • Virtu Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Virtu Financial sold 15,177 Global Blood Therapeutics, Inc. shares in Q3 2021, an estimated $531K.
  • Virtu Financial first reported a position in Global Blood Therapeutics, Inc. in Q3 2017 and held it in 12 quarters.
  • Virtu Financial's Global Blood Therapeutics, Inc. position peaked at $921K in Q3 2018.
  • 187 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2021.

Based on Virtu Financial's 13F filing for Q3 2021, filed 12 Nov 2021.